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INTRODUCTION 
Drug utilization is defined as the study of usage of drugs 
in the community or race. The drug utilization evaluation 
studies (DUES) aims to analyse the rationality of drugs 
usage and also describes the nature and drug 
exposure,and may also help to identify non-adherence 
problems. In a developing country India, Diabetes 
mellitus is a clinical issue in population. The type II 
diabetes mellitus has more prevalence among Indian 
individuals. 
Diabetes Mellitus complicationsare likely to reduce the 
quality of life of patient and owned as national public 
health issue3. Type II diabetes population have higher 
risk of death from CVD when compared to non-diabetes 
population. Type II diabetes population ofmajorityis 
under the general practitioners and efficiently able to 
control hyperglycemias.  Specialists are credited for the 
failure of achievement of glycaemic control.Specialists 
like cardiologists, endocrinologists, ophthalmologists 
plays prominent role.In critical care both Type-I and 
Type-II Diabetes management is done by Insulintherapy 
and educating patients. Self management is known 
aspectin Diabetic population.Prevalence in India is 
increasing day by day and the awareness in the increase 
population is rare. These two are the main factors which 
are really affecting the Indian public health and quality 
of life. Complications that affect the quality life are 
diabetic nephropathy, diabetic retinopathy and diabetic 
neuropathy occurring due to poor glycaemic control.By 
creating awareness improves cost effectiveness and 
benefits the diabetic patient quality of life.Requirement 
of rationalized therapy, proper monitoring and proper 
patient counselling that helps patients in attaining 
glycaemic control. Adherence to diet, drugs, exercise, 
monitoring of blood glucose, care of foot are the self care 
activities. Proper assessment of patient clinical condition 
and knowledge of self management on diabetes enacts 
proper interventions to be effective in glycaemic control 
in various studies.
6
Invigorate assessment of glycaemic 
control in diabetics patients likely avoids different 
complications of eye, Heart, kidney, etc. 
ABSTRACT 
Drug utilization is defined as the study of usage of drugs in the community or race. The drug utilization evaluation studies 
(DUES) aims to analyse the rationality of drugs usage and also describes the nature and drug exposure, and may also help to 
identify non-adherence problems. In a developing country India, Diabetes mellitus is a clinical issue in population. The type II 
diabetes mellitus has more prevalence among Indian individuals. The objectives of the study were to evaluate the Prescription 
pattern, assessment of Drug Interactions and To evaluate the occurrence of Diabetes with other comorbidities. A prospective 
observational study was conducted in Basaveswara Medical College Hospital and Research Centre, Chitradurga. The study 
was conducted for a period of six months from December-2012 to May-2013.Out of 201 patients, 101 patients were males and 
100 patients were females and large numbers of diabetic patients were between the age group of 51-60 year. in case of 
prescription pattern, more number of patients prescribed with Monotherapy (68.15%), among the monotherapy, Insulin was 
largely prescribed (76.64%). Among the combination therapy Glimiperide with Metformin was largely prescribed. Total 154 
prescriptions found with Drug Interactions. Out of all DI’s, Moderate drug interactions are more (42.78%), followed by Minor 
(19.4%) and Major Drug Interactions (14.42%). The present study concluded sulfonylureas was the most commonly prescribed 
oral hypoglycaemic drug in this hospital followed by combination with biguanides (i.e. Glimepiride with metformin)..Among 
insulin therapy, human actrapid (regular) was most commonly prescribed drug. 
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Factors that contributes to DM: 
Highly increased glucose level (hyperglycaemia) is 
referred as Diabetes. Type II diabetespatients can also 
have hypertension, chronic high levels of insulin and 
hyperlipidaemia. These factors contribute to the long-
term complications of diabetes includes the following:   
Impact on memory: Studies have shown diabetes to 
increased risk factor of memory loss, early Alzheimer’s 
disease and also cognitive deficits. 
Diabetic neuropathy: Peripheral neuropathy always 
causes pain otherwise numbness in the limbs, and 
autonomic neuropathy, which causesgastro-paresis and 
contributes to decreased sexual instinct and incontinence. 
Eye diseases: Diabetes is a mostly cause of visual 
impairment and blindness including diabetic retinopathy, 
glaucoma and cataracts.  
Atherosclerosis, Diabetic angiopathy, Heart 
conditions and Stroke: These cardiovascular disorders 
are leading cause of diabetic patient death, in which self 
management of diabetes becomes difficult. 
Diabetic nephropathy: Chief cause of end-stage of 
renal disease is diabetes. The requirementof dialysis or 
kidney transplantation makes patient condition critical. 
Wounds and Infections: Diabetic patient wounds are of 
poor healing and leads to cause of non-traumatic foot and 
leg amputations. Diabetes population can beprone to 
infections such as periodontal disease, thrush, urinary 
tract infections and yeast infections. 
Musculo-skeletal disorders: Conditions from gout to 
osteoporosis and restless legs syndrome to myofascial 
pain syndrome ranges more commonly in diabetic 
patients7. 
There are several guidelinesexisting for diabetes 
management by maintaining proper diet.The guidelines 
are proposed to provide evidence-based nutritional 
recommendations by healthcare professionals for the 
people who are at risk of, and those living with 
complications. Appropriate food choices are proven to 
reduce the risk of Type II diabetes and diabetes-
associated tissue damage obtains optimal glycaemic 
control and increases the quality of life. Specified diet is 
an important put forth for diabetic patient in the effective 
management of diabetes and helps to maintain optimal 
glycaemic control and reduces the risk of long-term 
tissue damage. The Diabetes UK 2011 explores to the 
extent that all members of the multidisciplinary team can 
deliver and implement evidence-based nutritional 
advices. All advices should be based upon scientific 
evidence-based and taking an account of personal and 
cultural preferences, beliefs, lifestyle; and the advices 
should beprovided for an individual in lucid language 
either by orally or as a leaflet or both preferably by 
patient. 
Notably, these guidelines are to be:  
 Support self-management to reduce the 
complications of Type II diabetes and the co-
morbidities associated 
 To improve quality of life 
 To meet the needs of all individuals, including those 
with co-morbidities; e.g. coeliac disease and cystic 
fibrosis8. 
Cancer: Diabetes increases the risk of malignant 
tumours in thepancreas, colon, liver and several other 
organs.  
OBJECTIVES 
General objective: 
 To evaluate the Drug utilization in diabetic patients 
in a tertiary care teaching hospital. 
Specific objectives: 
 Determine demographic and clinical characteristics 
of inpatients  
 To evaluate the Prescription pattern of Anti Diabetic 
drugs 
 To assess the severity of Drug Interactions  
 To evaluate the occurrence of Diabetes with other 
comorbidities  
METHODOLOGY 
Study site:  
The study was conducted in Basaveswara Medical 
College Hospital & Research Centre, Chitradurga. It is 
650 bedded multi-speciality tertiary care teaching 
hospital. It consists of various departments like General 
Medicine, OBG, Paediatrics, Orthopaedics, Surgery, 
Psychiatry, ENT, Dermatology, Casuality and Pharmacy. 
Approximately 200-250 patients are being treated in 
general medicine department per month. The patients 
who visit this hospital are usually from in and around 
district of Chitradurga.  
Study design: 
Thestudy was a prospective observational study, which 
assessed the drug utilization in diabetic patients. 
Study duration: 
The study was conducted for a period of six months from 
December 2012 to May 2013. 
Study criteria: 
 Inclusion Criteria: 
1. Newly diagnosed and known cases of Diabetes 
Mellitus with comorbidities who were receiving 
anti-hyperglycemics and patients who were 
hospitalized included. 
2. Inpatients of either sex or patients aged 18 years and 
above were included. 
 Exclusion Criteria: 
1. Patients with gestational diabetes were excluded 
from the study. 
2. Out patients are also excluded from our study 
Source of data: 
The patient demographical data, clinical data, therapeutic 
data and various other relevant and necessary data 
collected from: 
 Medical records of inpatients 
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 Personal interview of patients to determine the chief 
complaint, history of the present illness, past 
medical and medication history. 
 Patient’s prescriptions 
 Interviews of patient care takers 
Study procedure: 
All the patients who admitted to the General Medicine 
department were reviewed daily to identify the patients 
diagnosed with Diabetes or with other co morbidities. 
The patients who met the study criteria were enrolled in 
the study. Ethical clearance from Institutional Ethical 
Committee, by Basaveswara Medical College Hospital & 
Research Centre, Chitradurga was obtained prior to the 
study. A suitable data collection form designed 
(Annexure-III) to collect all the relevant and necessary 
data. The demographic details of the patient such as 
name, age, sex, IP number; clinical data such as 
diagnosis, clinical condition; therapeutic data such as 
name of the drug, dose, route, frequency, duration of 
therapy and other relevant details were collected by 
reviewing the case notes, treatment charts, lab data 
reports and by interviewing the patients and patient care 
takers. A personal visit was made to all the patients who 
were included in the study to collect any further 
information. Their medications were crosschecked with 
the treatment chart. 
All the patients were monitored from the day of 
admission to the day of discharge. During the treatment 
with anti- diabetic drugs the enrolled patients were 
evaluated clinically every day to assess the clinical 
outcome. The patients were also monitored for possible 
Drug Interactions during the course of treatment with 
Anti- Diabetic drugs. 
Data analysis:  
All the data was analysed in order to assess the drug 
utilization in diabetic patients, to evaluate the 
prescription pattern, drug interactions and other illness 
associated with Diabetes. Analysis is also based on 
evaluating the potential drug interactions. The data was 
analysed and the percentage value was calculated for the 
use of different class of oral anti-diabetics in medicine 
unit. 
RESULTS: 
A total of 201 patients aged 18 years and above admitted 
to the hospital who were known case of DM and newly 
detected diabetic patients were enrolled in the study.  
Demographic details: 
Out of 201 patients, males were 101(50.25%) and 
females were 100(49.75%). From the analysed data we 
found that, the large number of diabetic patients were  at 
the age group of 51–60 years (26.86%), followed by 61–
70 years (25.37%), 41–50 years (18.90%), 71–80 years  
(17.41%), 31–40 years (5.97%)  and above 80 years  
(1.99%).
 
Table 1: Distribution of the diabetic patients according to Age (n=201) 
Age group(Years) No of patients Percentage 
21 – 30 7 3.48% 
31 – 40 12 5.97% 
41 – 50 38 18.90% 
51 – 60 54 26.86% 
61 – 70 51 25.37% 
71 – 80 35 17.41% 
81 and above 4 1.99% 
Total 201 100% 
 
Co Morbidities in Diabetic patients: 
Out of 201 patients, 152 patients (75.62%) were 
identified with co morbidities and 49 patients (24.37%) 
were without co morbidities. From the data, Out of 152 
co morbid associated  patients 92 were encountered with 
cardiovascular diseases (60.52%), followed by 37 
patients were experienced with infectious diseases 
(24.34%), 12 patients were experienced with respiratory 
diseases (7.89%) and 11 patients with Renal failure 
(7.23%). 
 
Table 3: Details of Co morbidities in Diabetic patients (n=152) 
Co morbidities No of patients Percentage 
Cardiovascular diseases 92 60.52% 
Infectious diseases 37 24.34% 
Respiratory diseases 12 7.89% 
Renal failure 11 7.23% 
Total  152 100% 
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Prescription pattern of Anti Diabetic drugs: 
Study revealed that out of 201 patients, 137 patients were 
on Monotherapy (68.15%) followed by 47 patients were 
on Two drug combination therapy (23.38%), 14 patients 
were on Three drug combination therapy (6.96%) and 3 
patients were on Four drug combination therapy (1.49%).
 
Table 4: Mono therapy and Combination therapy of Anti Diabetic drugs (n=201) 
Drug therapy No of patients Percentage 
Mono therapy 137 68.15% 
Two drug combination therapy 47 23.38% 
Three drug combination therapy 14 6.96% 
Four drug combination therapy 3 1.49% 
Total  201 100% 
 
Assessment of Drug Interactions: 
Among 201 prescriptions, 154 prescriptions were found 
with drug interactions. Out of those, Major(Highly 
clinically significant. Avoid combinations; the risk of the 
interaction outweighs the benefit) drug interactions in 
14.42% prescriptions, Moderate (Moderately clinically 
significant. Usually avoid combinations; use it only 
under special circumstances).drug interactions in 43.28% 
prescriptions and Minor(Minimally clinically significant. 
Minimize risk; assess risk and consider an alternative 
drug, take steps to circumvent the interaction risk and/or 
institute a monitoring plan) drug interactions in 
18.9%prescriptions respectively.  
 
Table 4: Distribution of diabetic patients according to severity of Drug Interactions (n=201) 
Severity of Drug Interaction No of patients   Percentage 
Major 29 14.42% 
Moderate 87 43.28% 
Minor 38 18.9% 
No Interactions 47 23.38% 
 
DISCUSSION 
Drug utilization study is known to be one of the most 
effective methods to assess and evaluate the physicians 
prescribing natureand their by to promote rational use of 
drugs1. This is a cross sectional study conducted on 
subjects having diabetes, who visits doctor in tertiary 
care hospital, essentially focusing on drug utilization 
among diabetes patients. 
The necessity of management of diabetes by drugs is to 
lessen the morbidity, mortality and to improve the 
patient’s life quality. Patient’s demographic details are 
considered while taking measures for adequate control of 
plasma glucose including co-morbid conditions. After 
newly diagnosed; especially when the initial A1C is less 
than 8%, any available anti-hyperglycaemic drugs are 
capable of controlling hyperglycaemia. Oral agents can 
be used as additives for therapeutic effects, especially at 
lower doses. Individualization is often necessary asinitial 
choices make patients clinical situations vary widely. So 
the drug choice for managementshould be based on some 
considerations, which are mentioned in the following: 
 Contraindications 
 Synergy of mechanisms of action 
 Therapeutic response 
 Side effects likely to occur 
 Hypoglycaemia 
 Oedema  
 Weight gain 
 Cost effectiveness 
 Convenience and adherence 
 In the clinical situations, the best initial choice is a 
sulfonylurea, as they are effective as any other. Special 
directions are to be given for administration of drug, 
storage, side effects and management of side effects. 
Pharmacotherapy only by one drug cannot control blood 
glucose level when highly elevated, will have to employ 
another drug to gain the adequate response. For example, 
the combination of sulfonylureas with metformin, has 
maximum potency to lower the blood glucose levels and 
favours these agents include low cost. However, there is 
an in vigorous rationale for using this combination 
before titrating to full dosage of the first agent and the 
therapeutic effects are not proportional. Metformin side 
effects increase progressively like gastrointestinal 
discomfort for patients at 2,000 mg/day. For example, 
adding 2-4 mg of glimepiride or 5-10 mg extended-
release glipizideonce daily to 500-1000 mg metformin 
with supper reduces blood glucose level without risk of 
gastrointestinal distress. Insulin is given when oral 
therapy response is inadequate.Based on 
individualization of patients clinical situation the 
approach of insulin in the management of diabetes has to 
be considered along with oral agents or insulin alone as 
per the drug therapeutic response on patient. 
CONCLUSION 
The present study concluded sulfonylureas was the most 
commonly prescribed oral hypoglycaemic drug in this 
hospital followed by combination with biguanides (i.e. 
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Glimepiride with metformin)..Among insulin therapy, 
human actrapid (regular) was most commonly prescribed 
drug.drug interactionsare checked by Medscape 
interaction checker in that most of the interactions are 
moderate type and 90% cases are co-morbid condition.
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